{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:18:32Z","timestamp":1793261912114,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11033-020-06086-y","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T09:04:07Z","timestamp":1609751047000},"page":"887-896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["An update on vascular calcification and potential therapeutics"],"prefix":"10.1007","volume":"48","author":[{"given":"Anubha","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3720-0455","authenticated-orcid":false,"given":"Chanderdeep","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"6086_CR1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00223-013-9712-z","volume":"93","author":"M Wu","year":"2013","unstructured":"Wu M, Rementer C, Giachelli CM (2013) Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int 93:365\u2013373","journal-title":"Calcif Tissue Int"},{"key":"6086_CR2","doi-asserted-by":"publisher","first-page":"C210","DOI":"10.1152\/ajpcell.00229.2010","volume":"300","author":"R Sebastian","year":"2011","unstructured":"Sebastian R, Contiguglia AC, Alfrey NL et al (2011) Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. Am J Physiol 300:C210\u2013C220","journal-title":"Am J Physiol"},{"key":"6086_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000096744","volume":"44","author":"HR Mackey","year":"2007","unstructured":"Mackey HR, Sutton-Tyrrell K (2007) Calcifications, arterial stiffness and atherosclerosis. Adv Cardiol 44:234\u2013244","journal-title":"Adv Cardiol"},{"key":"6086_CR4","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1097\/01.ASN.0000145894.57533.C4","volume":"15","author":"CM Giachelli","year":"2004","unstructured":"Giachelli CM (2004) Vascular calcification mechanisms. J Am Soc Nephrol 15:2959\u20132964","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"6086_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.114.008729","volume":"133","author":"D Prabhakaran","year":"2016","unstructured":"Prabhakaran D, Jeemon P, Roy A (2016) Cardiovascular diseases in India current epidemiology and future directions. Circulation 133(16):1605\u20131620","journal-title":"Circulation"},{"issue":"21","key":"6086_CR6","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.3390\/ijms21082685","volume":"2020","author":"SN Lee","year":"2020","unstructured":"Lee SN, Lee IK, Jeon JH (2020) Vascular calcification\u2014new insights into its mechanism. Int J Mol Sci 2020(21):2685","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6086_CR7","first-page":"1","volume":"95","author":"D Zhu","year":"2012","unstructured":"Zhu D, Mackenzie CWN, Farquharson C et al (2012) Mechanisms and clinical consequences of vascular calcification. Front Endocrinol 95(3):1\u201312","journal-title":"Front Endocrinol"},{"key":"6086_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/cvr\/cvt040","volume":"99","author":"M Back","year":"2013","unstructured":"Back M, Gasser CT, Michel JB et al (2013) Biomechanical factors in the biology of aortic wall and aortic valve diseases. Cardiovasc Res 99:232\u2013241","journal-title":"Cardiovasc Res"},{"issue":"16","key":"6086_CR9","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/circ.104.16.1881","volume":"104","author":"LL Demer","year":"2001","unstructured":"Demer LL, Tintut Y (2001) Vascular calcification: pathobiology of a multifaceted disease. Circulation 104(16):1881\u20131883","journal-title":"Circulation"},{"key":"6086_CR10","doi-asserted-by":"publisher","first-page":"11201","DOI":"10.1073\/pnas.1932554100","volume":"100","author":"TM Doherty","year":"2003","unstructured":"Doherty TM, Asotra K, Fitzpatrick LA et al (2003) Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A 100:11201\u201311206","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6086_CR11","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.ajpath.2011.02.004","volume":"178","author":"RB Roijers","year":"2011","unstructured":"Roijers RB, Debernardi N, Cleutjens JP et al (2011) Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries. Am J Pathol 178:2879\u20132887","journal-title":"Am J Pathol"},{"key":"6086_CR12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1161\/01.ATV.0000133194.94939.42","volume":"24","author":"M Abedin","year":"2004","unstructured":"Abedin M, Tintut Y, Demer LL (2004) Vascular calcification mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24:1161\u20131170","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"6086_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3390\/nano9111570","volume":"9","author":"TJ Levingstone","year":"2019","unstructured":"Levingstone TJ, Herbaj S, Dunne NJ (2019) Calcium phosphate nanoparticles for therapeutic applications in bone regeneration. Nanomaterials (Basel) 9(11):1570","journal-title":"Nanomaterials (Basel)"},{"key":"6086_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/01.ATV.0000110786.02097.0c","volume":"24","author":"MA Allison","year":"2004","unstructured":"Allison MA, Criqui MH, Wright CM (2004) Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 24:331\u2013336","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"35","key":"6086_CR15","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","volume":"2014","author":"P Lanzer","year":"2014","unstructured":"Lanzer P, Boehm M, Sorribas V et al (2014) Medial vascular calcification revisited: review and perspectives. Eur Heart J 2014(35):1515\u20131525","journal-title":"Eur Heart J"},{"key":"6086_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.semnephrol.2004.06.005","volume":"24","author":"CM Giachelli","year":"2004","unstructured":"Giachelli CM (2004) Mechanisms of vascular calcification in uremia. Semin Nephrol 24:401\u2013402","journal-title":"Semin Nephrol"},{"key":"6086_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1365-2796.2006.01692.x","volume":"260","author":"VP Iyemere","year":"2006","unstructured":"Iyemere VP, Proudfoot D, Weissberg PL et al (2006) Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 260:192\u2013210","journal-title":"J Intern Med"},{"key":"6086_CR18","doi-asserted-by":"publisher","first-page":"E686","DOI":"10.1152\/ajpendo.00552.2003","volume":"286","author":"R Vattikuti","year":"2004","unstructured":"Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286:E686\u2013E696","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6086_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.molmed.2019.08.006","volume":"25","author":"G Van den Bergh","year":"2019","unstructured":"Van den Bergh G, Opdebeeck B, D\u2019Haese PC et al (2019) The vicious cycle of arterial stiffness and arterial media calcification. Trends Mol Med 25:1133\u20131146","journal-title":"Trends Mol Med"},{"key":"6086_CR20","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1536\/ihj.18-363","volume":"60","author":"X Ren","year":"2019","unstructured":"Ren X, Li F, Wang C et al (2019) Age- and sex-related aortic valve dysfunction and aortopathy difference in patients with bicuspid aortic valve. Int Heart J 60:637\u2013642","journal-title":"Int Heart J"},{"key":"6086_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11886-014-0487-2","volume":"16","author":"S LaHaye","year":"2014","unstructured":"LaHaye S, Lincoln J, Garg V (2014) Genetics of valvular heart disease. Curr Cardiol Rep 16:487","journal-title":"Curr Cardiol Rep"},{"key":"6086_CR22","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.3892\/etm.2016.3048","volume":"11","author":"YI Zeng","year":"2016","unstructured":"Zeng YI, Sun R, Li X et al (2016) Pathophysiology of valvular heart disease. Exp Ther Med 11:1184\u20131188","journal-title":"Exp Ther Med"},{"issue":"14","key":"6086_CR23","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/clc.4960141210","volume":"1991","author":"ER Mohler","year":"1991","unstructured":"Mohler ER, Sheridan MJ, Nichols R et al (1991) Development and progression of aortic valve stenosis: atherosclerosis risk factors\u2014a causal relationship? Aclinical morphologic study. Clin Cardiol 1991(14):995\u2013999","journal-title":"Clin Cardiol"},{"key":"6086_CR24","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1046\/j.1523-1755.62.s82.15.x","volume":"82","author":"WY Qunibi","year":"2002","unstructured":"Qunibi WY, Nolan CA, Ayus JC (2002) Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon. Kidney Int 82:S73\u2013S80","journal-title":"Kidney Int"},{"key":"6086_CR25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1097\/PAS.0000000000001302","volume":"43","author":"ER McMullen","year":"2019","unstructured":"McMullen ER, Harms PW, Lowe L et al (2019) Clinicopathologic features and calcium deposition patterns in calciphylaxis: comparison with gangrene, peripheral artery disease, chronic stasis, and thrombotic vasculopathy. Am J Surg Pathol 43:1273\u20131281","journal-title":"Am J Surg Pathol"},{"key":"6086_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.nefro.2018.05.007","volume":"38","author":"D Cucchiari","year":"2018","unstructured":"Cucchiari D, Torregrosa JV (2018) Calciphylaxis in patients with chronic kidney disease: a disease which is still bewildering and potentially fatal. Nefrologia 38:579\u2013586","journal-title":"Nefrologia"},{"key":"6086_CR27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1523-1755.2001.00803.x","volume":"60","author":"AR Mazhar","year":"2001","unstructured":"Mazhar AR, Johnson RJ, Gillen D et al (2001) Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60:324\u2013332","journal-title":"Kidney Int"},{"key":"6086_CR28","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/ndt\/gfl114","volume":"21","author":"N Velasco","year":"2006","unstructured":"Velasco N, MacGregor MS, Innes A et al (2006) Successful treatment of calciphylaxis with cinacalcet-an alternative to parathyroidectomy? Nephrol Dial Transplant 21:1999\u20132004","journal-title":"Nephrol Dial Transplant"},{"key":"6086_CR29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1053\/ajkd.1998.v32.pm9740152","volume":"32","author":"AJ Bleyer","year":"1998","unstructured":"Bleyer AJ, Choi M, Igwemezie B et al (1998) A case control study of proximal calciphylaxis. Am J Kidney Dis 32:376\u2013383","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"6086_CR30","first-page":"E212","volume":"83","author":"J Krishna","year":"2014","unstructured":"Krishna J, Singh R, Zeller T et al (2014) Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Cardiovasc Interv 83(6):E212\u2013E220","journal-title":"Cardiovasc Interv"},{"key":"6086_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yexcr.2015.02.002","volume":"333","author":"N Chavkin","year":"2015","unstructured":"Chavkin N, Chia J, Crouthamel M et al (2015) Phosphate uptake-independent signaling functions of the type III sodium-dependent phosphate transporter, PiT-1, in vascular smooth muscle cells. Exp Cell Res 333:39\u201348","journal-title":"Exp Cell Res"},{"issue":"1","key":"6086_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/ijcep.ijcep_3_17","volume":"4","author":"L Melaku","year":"2017","unstructured":"Melaku L, Mossie A (2017) Molecular mediators and controlling mechanism of vascular calcification. Clin Exp Physiol 4(1):3\u201314","journal-title":"Clin Exp Physiol"},{"key":"6086_CR33","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrcardio.2010.115","volume":"7","author":"A Sage","year":"2010","unstructured":"Sage A, Tintut Y, Demer LL (2010) Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7:528\u2013536","journal-title":"Nat Rev Cardiol"},{"key":"6086_CR34","doi-asserted-by":"publisher","first-page":"25706","DOI":"10.1074\/jbc.M112.361360","volume":"287","author":"T Yoshida","year":"2012","unstructured":"Yoshida T, Yamashita M, Hayashi M (2012) Kr\u00fcppel-like factor 4 contributes to high phosphate-induced phenotypic switching of vascular smooth muscle cells into osteogenic cells. J Biol Chem 287:25706\u201325714","journal-title":"J Biol Chem"},{"issue":"5","key":"6086_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/kisup.2013.92","volume":"3","author":"MG London","year":"2013","unstructured":"London MG (2013) Mechanisms of arterial calcifications and consequences for cardiovascular function. Kidney Int Suppl 3(5):442\u2013445","journal-title":"Kidney Int Suppl"},{"issue":"7","key":"6086_CR36","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.ajpath.2015.03.020","volume":"185","author":"M Lin","year":"2015","unstructured":"Lin M, Chen T, Leaf EM (2015) Runx2 expression in smooth muscle cells is required for arterial medial calcification in mice. Am J Pathol 185(7):1958\u20131969","journal-title":"Am J Pathol"},{"issue":"11","key":"6086_CR37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/toxins11110647","volume":"11","author":"I Vogt","year":"2019","unstructured":"Vogt I, Haffner D, Nestler ML (2019) FGF23 and phosphate\u2013cardiovascular toxins in CKD. Toxins (Basel) 11(11):647","journal-title":"Toxins (Basel)"},{"key":"6086_CR38","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S8756-3282(02)00821-9","volume":"31","author":"M Roy","year":"2002","unstructured":"Roy M, Nishimoto S (2002) Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone 31:296\u2013302","journal-title":"Bone"},{"key":"6086_CR39","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1038\/s41598-020-63013-8","volume":"10","author":"AMG Jaminon","year":"2020","unstructured":"Jaminon AMG, Dai L, Qureshi AR et al (2020) Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease. Sci Rep 10:6586","journal-title":"Sci Rep"},{"key":"6086_CR40","doi-asserted-by":"publisher","first-page":"23029","DOI":"10.1161\/ATVBAHA.107.144824","volume":"27","author":"M Scatena","year":"2007","unstructured":"Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27:23029","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6086_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/ATVBAHA.118.311577","volume":"39","author":"Y Lok","year":"2019","unstructured":"Lok Y, Lyle N (2019) Osteopontin in vascular disease friend or foe? Arterioscler Thromb Vasc Biol 39:613\u2013622","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6086_CR42","doi-asserted-by":"publisher","first-page":"93546","DOI":"10.2337\/db09-0404","volume":"59","author":"W Kiefer","year":"2010","unstructured":"Kiefer W, Zeyda M, Gollinger K et al (2010) Neutralization of osteopontin inhibits obesity induced inflammation and insulin resistance. Diabetes 59:93546","journal-title":"Diabetes"},{"key":"6086_CR43","first-page":"104657","volume":"95","author":"PC Osdoby","year":"2004","unstructured":"Osdoby PC (2004) Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 95:104657","journal-title":"Circ Res"},{"key":"6086_CR44","doi-asserted-by":"publisher","first-page":"16576","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"D Lacey","year":"1998","unstructured":"Lacey D, Timms E, Tan H et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:16576","journal-title":"Cell"},{"key":"6086_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bone.2015.05.046","volume":"82","author":"M Zoch","year":"2016","unstructured":"Zoch M, Clemens T, Riddle R (2016) New insights into the biology of osteocalcin. Bone 82:42\u201349","journal-title":"Bone"},{"key":"6086_CR46","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/01.RES.0000026421.61398.F2","volume":"91","author":"A Shioi","year":"2002","unstructured":"Shioi A, Katagi M, Okuno Y et al (2002) Induction of bone type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor alpha and oncostatin M derived from macrophages. Circ Res 91:916","journal-title":"Circ Res"},{"key":"6086_CR47","doi-asserted-by":"publisher","first-page":"48594","DOI":"10.1161\/CIRCRESAHA.110.219071","volume":"107","author":"Y Yao","year":"2010","unstructured":"Yao Y, Bennett BJ, Wang X et al (2010) Inhibition of bone morphogenetic proteins protects against atherosclerosis and vascular calcification. Circ Res 107:48594","journal-title":"Circ Res"},{"key":"6086_CR48","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1046\/j.1523-1755.2003.00035.x","volume":"63","author":"S Wang","year":"2003","unstructured":"Wang S, Chen Q, Simon TC et al (2003) Bone morphogenetic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int 63:2037\u20132049","journal-title":"Kidney Int"},{"key":"6086_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M","volume":"184","author":"H Dorai","year":"2000","unstructured":"Dorai H, Vukicevic S, Sampath TK (2000) Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol 184:37\u201345","journal-title":"J Cell Physiol"},{"key":"6086_CR50","doi-asserted-by":"publisher","first-page":"53743","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans W, Ebeling M, Patel N et al (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:53743","journal-title":"Hum Mol Genet"},{"key":"6086_CR51","doi-asserted-by":"publisher","first-page":"12755","DOI":"10.1074\/jbc.271.22.12755","volume":"271","author":"M Demetriou","year":"1996","unstructured":"Demetriou M, Binkert C, Sukhu B et al (1996) Fetuin\/alpha2-HS glycoprotein is transforming growth factor-beta type II receptor mimic and cytokine antagonist. J Biol Chem 271:12755\u201312761","journal-title":"J Biol Chem"},{"issue":"9","key":"6086_CR52","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4103\/0366-6999.204931","volume":"130","author":"N Hern\u00e1ndez","year":"2017","unstructured":"Hern\u00e1ndez N, Duque G, Braun R et al (2017) Vascular calcification: current genetics underlying this complex phenomenon. Chin Med J 130(9):1113\u20131121","journal-title":"Chin Med J"},{"key":"6086_CR53","first-page":"57892","volume":"109","author":"F Rutsch","year":"2012","unstructured":"Rutsch F, Nitschke Y, Terkeltaub R (2012) Genetics in arterial calcification pieces of a puzzle and cogs in a wheel. Circ Res 109:57892","journal-title":"Circ Res"},{"key":"6086_CR54","first-page":"938","volume":"22","author":"M Bowman","year":"2012","unstructured":"Bowman M, McNally E (2012) Genetic pathways of vascular calcification. Trends Cardiovasc Med 22:938","journal-title":"Trends Cardiovasc Med"},{"key":"6086_CR55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajhg.2011.11.020","volume":"90","author":"Y Nitschke","year":"2012","unstructured":"Nitschke Y, Baujat G, Botschen U et al (2012) Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 90:25\u201339","journal-title":"Am J Hum Genet"},{"key":"6086_CR56","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJMoa0912923","volume":"364","author":"C St Hilaire","year":"2011","unstructured":"St Hilaire C, Ziegler SG, Markello T et al (2011) NT5E mutations and arterial calcifications. N Engl J Med 364:432\u2013442","journal-title":"N Engl J Med"},{"key":"6086_CR57","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1161\/CIRCULATIONAHA.110.974899","volume":"124","author":"C O\u2019Donnell","year":"2011","unstructured":"O\u2019Donnell C, Kavousi M, Smith AV et al (2011) Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation 124:2855\u20132864","journal-title":"Circulation"},{"key":"6086_CR58","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/hq0302.105721","volume":"22","author":"L Lange","year":"2002","unstructured":"Lange L, Lange E, Bielak L et al (2002) Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler Thromb Vasc Biol 22:418\u2013423","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6086_CR59","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1109034","volume":"368","author":"G Thanassoulis","year":"2013","unstructured":"Thanassoulis G, Campbell CY, Owens D et al (2013) Genetic associations with valvular calcification and aortic stenosis. N Engl J Med 368:503\u2013512","journal-title":"N Engl J Med"},{"key":"6086_CR60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/CIRCGEN.119.002617","volume":"12","author":"S Th\u00e9riault","year":"2019","unstructured":"Th\u00e9riault S, Dina C, Zeitoun DM et al (2019) Genetic association analyses highlight IL6, ALPL, and NAV1 as 3 new susceptibility genes underlying calcific aortic valve stenosis. Circ Genom Precis Med 12:431\u2013441","journal-title":"Circ Genom Precis Med"},{"issue":"1","key":"6086_CR61","first-page":"10","volume":"40","author":"S Chan","year":"2017","unstructured":"Chan S (2017) Phosphate binders in patients with chronic kidney disease. Aust Prescr 40(1):10\u201314","journal-title":"Aust Prescr"},{"key":"6086_CR62","doi-asserted-by":"crossref","unstructured":"Schantl A, Ivarsson M, Leroux J (2018) Investigational pharmacological treatments for vascular calcification. Adv Therap:1\u201316","DOI":"10.1002\/adtp.201800094"},{"issue":"1","key":"6086_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ki.2012.69","volume":"82","author":"PA Torres","year":"2012","unstructured":"Torres PA, De Broe M (2012) Calcium-sensing receptor, calcimimetics, and cardiovascular calcifications in chronic kidney disease. Kidney Int 82(1):19\u201325","journal-title":"Kidney Int"},{"issue":"12:3","key":"6086_CR64","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1681\/ASN.2006080927","volume":"17","author":"ALM de Francisco","year":"2006","unstructured":"de Francisco ALM, Pi\u00f1era C, Palomar R et al (2006) Impact of treatment with calcimimetics on hyperparathyroidism and vascular mineralization. JASN 17(12:3):S281\u2013S285","journal-title":"JASN"},{"issue":"3","key":"6086_CR65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.semnephrol.2018.02.005","volume":"38","author":"K Lim","year":"2018","unstructured":"Lim K, Hamano T, Thadhani R (2018) Vitamin D and calcimimetics in cardiovascular disease. Semin Nephrol 38(3):251\u2013266","journal-title":"Semin Nephrol"},{"key":"6086_CR66","doi-asserted-by":"crossref","unstructured":"Mozos I, Marginean O (2015) Links between vitamin D deficiency and cardiovascular diseases. Biomed Res Int:1\u201312","DOI":"10.1155\/2015\/109275"},{"issue":"7","key":"6086_CR67","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1080\/15384101.2015.1007809","volume":"14","author":"Q Li","year":"2015","unstructured":"Li Q, Sundberg JP, Levine MA et al (2015) The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene. Cell Cycle 14(7):1082\u20131089","journal-title":"Cell Cycle"},{"issue":"9","key":"6086_CR68","doi-asserted-by":"publisher","first-page":"nzz077","DOI":"10.1093\/cdn\/nzz077","volume":"3","author":"MK Shea","year":"2019","unstructured":"Shea MK, Booth SL (2019) Vitamin K, vascular calcification, and chronic kidney disease: current evidence and unanswered questions. Curr Dev Nutr 3(9):nzz077","journal-title":"Curr Dev Nutr"},{"issue":"2","key":"6086_CR69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3945\/an.111.001644","volume":"3","author":"MK Shea","year":"2012","unstructured":"Shea MK, Holden MR (2012) Vitamin K status and vascular calcification: evidence from observational and clinical studies. Adv Nutr 3(2):158\u2013165","journal-title":"Adv Nutr"},{"issue":"4","key":"6086_CR70","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000448184","volume":"134","author":"AY Adema","year":"2016","unstructured":"Adema AY, de Jong MA, de Brost MH et al (2016) Phosphate binding therapy to lower serum fibroblast-growth-Factor-23 concentrations in chronic kidney disease: rationale and study design of the Sevelamer on FGF23 Trial (SoFT). Nephron 134(4):215\u2013220","journal-title":"Nephron"},{"issue":"3","key":"6086_CR71","doi-asserted-by":"publisher","first-page":"153","DOI":"10.11005\/jbm.2018.25.3.153","volume":"25","author":"A Ghorbanihaghjo","year":"2018","unstructured":"Ghorbanihaghjo A, Argani H, Golmohamadi Z (2018) Linkage of fibroblast growth factor 23 and phosphate in serum: phosphate and fibroblast growth factor 23 reduction by increasing dose of sevelamer. J Bone Metab 25(3):153\u2013159","journal-title":"J Bone Metab"},{"issue":"1","key":"6086_CR72","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P (2002) Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62(1):245\u2013252","journal-title":"Kidney Int"},{"issue":"8","key":"6086_CR73","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1681\/ASN.2007080902","volume":"19","author":"S Mathew","year":"2008","unstructured":"Mathew S, Lund RJ, Chaudhary LR et al (2008) Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol 19(8):1509\u20131519","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"6086_CR74","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/tcrm.2006.2.3.297","volume":"2","author":"S Cheng","year":"2006","unstructured":"Cheng S, Coyne D (2006) Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease. Ther Clin Risk Manag 2(3):297\u2013301","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"6086_CR75","first-page":"391","volume":"22","author":"A Bellasi","year":"2013","unstructured":"Bellasi A, Reiner M, P\u00e9tavy F et al (2013) Presence of valvular calcification predicts the response to cinacalcet: data from the ADVANCE study. J Heart Valve Dis 22(3):391\u2013399","journal-title":"J Heart Valve Dis"},{"issue":"4","key":"6086_CR76","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.xkme.2020.05.009","volume":"2","author":"KH Anis","year":"2020","unstructured":"Anis KH, Pober D, Rosas SE (2020) Vitamin D analogues and coronary calcification in CKD stages 3 and 4: a randomized controlled trial of calcitriol versus paricalcitol. Kidney Med 2(4):450\u2013458","journal-title":"Kidney Med"},{"issue":"6","key":"6086_CR77","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ki.2008.646","volume":"75","author":"AK Lomashvili","year":"2009","unstructured":"Lomashvili AK, Monier-Faugere MC, Wang X et al (2009) Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 75(6):617\u2013625","journal-title":"Kidney Int"},{"issue":"2","key":"6086_CR78","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jbmr.1752","volume":"28","author":"JE Otero","year":"2013","unstructured":"Otero JE, Gottesman GS, McAlister WH et al (2013) Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy. J Bone Miner Res 28(2):419\u2013430","journal-title":"J Bone Miner Res"},{"issue":"2","key":"6086_CR79","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2013.01.032","volume":"167","author":"EV Giger","year":"2013","unstructured":"Giger EV, Castagner B, Leroux JC (2013) Biomedical applications of bisphosphonates. J Control Release 167(2):175\u2013188","journal-title":"J Control Release"},{"issue":"56","key":"6086_CR80","doi-asserted-by":"publisher","first-page":"30721","DOI":"10.18632\/oncotarget.10738","volume":"9","author":"Q Li","year":"2018","unstructured":"Li Q, Kingman J, Sundberg JP et al (2018) Etidronate prevents, but does not reverse, ectopic mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6\u2212\/\u2212). Oncotarget 9(56):30721\u201330730","journal-title":"Oncotarget"},{"issue":"11","key":"6086_CR81","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s11255-019-02275-2","volume":"51","author":"T Oikonomaki","year":"2019","unstructured":"Oikonomaki T, Papasotiriou M, Ntrinias T et al (2019) The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial. Int Urol Nephrol 51(11):2037\u20132044","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"6086_CR82","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1681\/ASN.2019060579","volume":"31","author":"AS De Vriese","year":"2020","unstructured":"De Vriese AS, Caluw\u00e9 R, Pyfferoen L et al (2020) Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: the Valkyrie study. J Am Soc Nephrol 31(1):186\u2013196","journal-title":"J Am Soc Nephrol"},{"key":"6086_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.atv.0000441188.68640.6c","volume":"34","author":"E Tantisattamo","year":"2014","unstructured":"Tantisattamo E, Han KH, Neill WCO (2014) Increased vascular calcification in patients receiving warfarin. Arterioscler Thromb Vasc Biol 34:1\u20136","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"6086_CR84","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.clnu.2016.04.024","volume":"36","author":"MD Fusaro","year":"2017","unstructured":"Fusaro MD, Alessandro C, Noale M et al (2017) Low vitamin K1 intake in haemodialysis patients. Clin Nutr 36(2):601\u2013607","journal-title":"Clin Nutr"},{"issue":"21","key":"6086_CR85","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1161\/CIRCULATIONAHA.116.027011","volume":"135","author":"VM Brandenburg","year":"2017","unstructured":"Brandenburg VM, Reinartz S, Kaesler N et al (2017) Slower progress of aortic valve calcification with vitamin K supplementation: results from a prospective interventional proof-of-concept study. Circulation 135(21):2081\u20132083","journal-title":"Circulation"},{"key":"6086_CR86","doi-asserted-by":"crossref","unstructured":"Haroon SW, Tai BC, Ling LH et al (2020) Treatment to reduce vascular calcification in hemodialysis patients using vitamin K (Trevasc-HDK): a study protocol for a randomized controlled trial. Medicine (Baltimore) 99(36)","DOI":"10.1097\/MD.0000000000021906"},{"key":"6086_CR87","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrneph.2009.99","volume":"5","author":"G Schlieper","year":"2009","unstructured":"Schlieper G, Brandenburget V, Ketteler M et al (2009) Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 5:539\u2013543","journal-title":"Nat Rev Nephrol"},{"key":"6086_CR88","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/ki.2008.455","volume":"74","author":"A Pasch","year":"2008","unstructured":"Pasch A, Schaffner T, Huynh-Do U et al (2008) Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 74:1444\u20131453","journal-title":"Kidney Int"},{"issue":"11","key":"6086_CR89","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1310\/hpj5011-975","volume":"50","author":"JA Generali","year":"2015","unstructured":"Generali JA, Cada DJ (2015) Sodium thiosulfate: calciphylaxis. Hosp Pharm 50(11):975\u2013977","journal-title":"Hosp Pharm"},{"issue":"1\u20133","key":"6086_CR90","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejphar.2009.05.013","volume":"616","author":"C Henley","year":"2009","unstructured":"Henley C, Davis J, Miller G et al (2009) The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. Eur J Pharmacol 616(1\u20133):306\u2013313","journal-title":"Eur J Pharmacol"},{"key":"6086_CR91","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1159\/000504139","volume":"44","author":"Y Zu","year":"2019","unstructured":"Zu Y, Lu X, Song J et al (2019) Cinacalcet treatment significantly improves all-cause and cardiovascular survival in dialysis patients: results from a meta-analysis. Kidney Blood Press Res 44:1327\u20131338","journal-title":"Kidney Blood Press Res"},{"key":"6086_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0197061","volume":"13","author":"MD Ferrer","year":"2018","unstructured":"Ferrer MD, Ketteler M, Tur F et al (2018) Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification. PLoS One 13:1\u201319","journal-title":"PLoS One"},{"key":"6086_CR93","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/35073015","volume":"2","author":"RF Irvine","year":"2001","unstructured":"Irvine RF, Schell MJ (2001) Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol 2:327\u2013338","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6086_CR94","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2741\/1786","volume":"11","author":"F Grases","year":"2006","unstructured":"Grases F, Sanchis P, Perello J et al (2006) Phytate (myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front Biosci 11:136\u2013142","journal-title":"Front Biosci"},{"issue":"9","key":"6086_CR95","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/CIRCULATIONAHA.119.044801","volume":"141","author":"SS Hedayati","year":"2020","unstructured":"Hedayati SS (2020) A novel treatment for vascular calcification in patients with dialysis-dependent chronic kidney disease. Circulation 141(9):740\u2013742","journal-title":"Circulation"},{"key":"6086_CR96","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41467-019-14091-4","volume":"11","author":"AE Schantl","year":"2020","unstructured":"Schantl AE, Verhulst A, Neven E et al (2020) Inhibition of vascular calcification by inositol phosphates derivatized with ethylene glycol oligomers. Nat Commun 11:721","journal-title":"Nat Commun"},{"issue":"4","key":"6086_CR97","first-page":"627","volume":"16","author":"W Dougall","year":"2006","unstructured":"Dougall W, Chaisson M (2006) Monoclonal antibody targeting RANKL as a therapy for cancer-induced bone diseases. Clin Calcium 16(4):627\u2013635","journal-title":"Clin Calcium"},{"issue":"2","key":"6086_CR98","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2353\/ajpath.2009.080957","volume":"175","author":"S Helas","year":"2009","unstructured":"Helas S, Goettsch C, Schoppet M et al (2009) Inhibition of receptor activator of NF-\u03baB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol 175(2):473\u2013478","journal-title":"Am J Pathol"},{"key":"6086_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.115.002499","volume":"4","author":"AY Savinov","year":"2015","unstructured":"Savinov AY, Salehi M, Yadav MC et al (2015) Transgenic overexpression of tissue-nonspecific alkaline phosphatase (TNAP) in vascular endothelium results in generalized arterial calcification. J Am Heart Assoc 4:1\u201313","journal-title":"J Am Heart Assoc"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06086-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-06086-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-06086-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T10:47:11Z","timestamp":1674816431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-06086-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["6086"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-06086-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"26 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No human studies were carried out by the authors for this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human rights"}}]}}